Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)

SHA:688739 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,961	4,496	4,548	5,797	2,829	985.19
Short-Term Investments	-	30.12	60.19	291.13	270.72	691.63
Trading Asset Securities	1,445	973.02	1,094	-	3,316	501.99
Cash & Short-Term Investments	5,406	5,500	5,702	6,088	6,416	2,179
Cash Growth	-3.11%	-3.55%	-6.33%	-5.12%	194.49%	28.16%
Accounts Receivable	1,125	1,077	1,082	1,111	958.17	510.92
Other Receivables	1.47	1.41	11.91	1.63	1.09	1.15
Receivables	1,127	1,078	1,094	1,113	959.27	512.07
Inventory	445.15	459.94	422.42	479.88	385.16	281.83
Prepaid Expenses	-	-	-	-	2.02	10.03
Other Current Assets	95.58	45.47	30.1	25.15	34.75	66.64
Total Current Assets	7,074	7,083	7,249	7,706	7,798	3,049
Property, Plant & Equipment	1,958	1,961	1,885	1,437	1,228	1,059
Long-Term Investments	132.41	132.37	225.07	258.56	305.31	157.39
Other Intangible Assets	185.74	181.45	178.87	187.21	123.35	126.61
Long-Term Deferred Tax Assets	41.05	35.72	42.39	30.29	25.08	13.5
Long-Term Deferred Charges	622.47	588.54	381.37	187.45	82.06	9.3
Other Long-Term Assets	67.06	69.22	120.21	249.49	231.61	63.12
Total Assets	10,081	10,052	10,081	10,056	9,793	4,478
Accounts Payable	267.11	5.22	15.76	16.33	3.1	4.89
Accrued Expenses	71.05	189.18	158.48	165.97	176.43	149.55
Current Portion of Leases	5.22	5.14	4.86	4.53	4.49	-
Current Income Taxes Payable	7.4	-	26.99	18.86	24.17	-
Current Unearned Revenue	0.39	3.65	1.97	0.16	3.1	4.66
Other Current Liabilities	2.15	190.12	148.73	67.12	77.72	69.77
Total Current Liabilities	353.32	393.31	356.79	272.99	289.01	228.87
Long-Term Leases	9.48	10	15.14	17.4	21.91	-
Long-Term Unearned Revenue	83.02	85.6	100.79	111.1	120.74	120.26
Long-Term Deferred Tax Liabilities	0.11	0.19	9.5	4.66	9.03	11.04
Other Long-Term Liabilities	0	0.01	0.01	0.01	0.02	0.01
Total Liabilities	445.94	489.12	482.23	406.16	440.72	360.17
Common Stock	416.45	416.45	416.45	416.45	416.45	374.8
Additional Paid-In Capital	5,034	5,034	5,034	5,034	5,034	734.44
Retained Earnings	4,334	4,262	4,248	4,199	3,901	3,009
Treasury Stock	-149.99	-149.99	-99.99	-	-	-
Shareholders' Equity	9,635	9,562	9,599	9,650	9,352	4,118
Total Liabilities & Equity	10,081	10,052	10,081	10,056	9,793	4,478
Total Debt	14.7	15.14	20.01	21.93	26.41	-
Net Cash (Debt)	5,392	5,484	5,682	6,066	6,390	2,179
Net Cash Growth	-3.03%	-3.48%	-6.33%	-5.07%	193.28%	28.16%
Net Cash Per Share	13.10	13.28	13.66	14.53	16.75	5.81
Filing Date Shares Outstanding	411.64	411.64	412.86	416.45	416.45	374.8
Total Common Shares Outstanding	411.64	411.64	413.47	416.45	416.45	374.8
Working Capital	6,721	6,690	6,892	7,433	7,509	2,821
Book Value Per Share	23.41	23.23	23.22	23.17	22.46	10.99
Tangible Book Value	9,449	9,381	9,420	9,462	9,229	3,992
Tangible Book Value Per Share	22.95	22.79	22.78	22.72	22.16	10.65
Buildings	-	992.14	912.41	713.81	663.04	670.46
Machinery	-	1,435	1,274	880.16	867.47	770.15
Construction In Progress	-	465.58	438.82	454.03	210.84	75.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.